-
NAD recommends Trinity Sports Group discontinue certain claims for 'NeuroImpact'
NEW YORK — The National Advertising Division has recommended that Trinity Sports Group discontinue certain claims for the company’s “NeuroImpact” dietary supplement, including claims that the product has been clinically tested.
NAD noted, however, that the advertiser provided a reasonable basis for “carefully qualified ingredient claims regarding the ability of certain ingredients,” in NeuroImpact “to support healthy brain function.”